Inventor · disambiguated record
Wayne Douglas Luke
Also filed as: LUKE WAYNE · LUKE WAYNE D · LUKE WAYNE DOUGLAS
22 granted patents·9 pending applications·172 citations·filing 1980–2024
94Inventor score
Files withLILLY CO ELI15LINNAEUS THERAPEUTICS INC6OMEROS CORP3PHOSPLATIN THERAPEUTICS LLC2ALKERMES INC1
Top patents by PatentIndex Score
31 records- 0190US8030330B2Benzothiophenes, formulations containing same, and methodsLILLY CO ELI·Filed 2010·Granted Oct 4, 2011·14 cites·5 claims
- 0289US6894064B2Benzothiophenes, formulations containing same, and methodsLILLY CO ELI·Filed 2004·Granted May 17, 2005·28 cites·12 claims
- 0388US6797719B2Benzothiophenes, formulations containing same, and methodsLILLY CO ELI·Filed 2002·Granted Sep 28, 2004·25 cites·73 claims
- 0482US6458811B1Benzothiophenes formulations containing same and methodsLILLY CO ELI·Filed 1997·Granted Oct 1, 2002·40 cites·17 claims
- 0578US2023382896A1Enantiomerically purified gper agonist for use in treating disease states and conditionsLINNAEUS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0678US2025171421A1Enantiomerically purified gper agonist for use in treating disease states and conditionsLINNAEUS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0773US5731327ASynthesis of 3- 4-(2-aminoethoxy)benzoyl!-2-aryl-6-hydroxybenzo b!thiophenesLILLY CO ELI·Filed 1995·Granted Mar 24, 1998·27 cites·12 claims
- 0872US9650368B2Processes and intermediates for the preparation of a PDE10 inhibitorOMEROS CORP·Filed 2015·Granted May 16, 2017·1 cites·77 claims
- 0970US10934277B2Enantiomerically purified GPER agonist for use in treating disease states and conditionsLINNAEUS THERAPEUTICS INC·Filed 2019·Granted Mar 2, 2021·0 cites·11 claims
- 1068US6653479B1Crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b] thiophene hydrochlorideLILLY CO ELI·Filed 2000·Granted Nov 25, 2003·2 cites·6 claims
- 1166US11760749B2Enantiomerically purified GPER agonist for use in treating disease states and conditionsLINNAEUS THERAPEUTICS INC·Filed 2021·Granted Sep 19, 2023·0 cites·11 claims
- 1266US2022089576A1Enantiomerically purified gper agonist for use in treating disease states and conditionsLINNAEUS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1361US5514826AVinyl sulfenic acid derivativesLILLY CO ELI·Filed 1995·Granted May 7, 1996·9 cites·17 claims
- 1461US2020024262A1Enantiomerically purified gper angonist for use in treating disease states and conditionsLINNAEUS THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1555US5512701AProcess for the synthesis of vinyl sulfenic acid derivativesLILLY CO ELI·Filed 1995·Granted Apr 30, 1996·6 cites·24 claims
- 1655US2005239840A1Benzothiophenes, formulations containing same, and methodsARBUTHNOT GORDON N·Filed 2005·Application pending·0 cites
- 1754US5569772AProcess for the synthesis of benzo[b]thiophenesLILLY CO ELI·Filed 1995·Granted Oct 29, 1996·5 cites·16 claims
- 1853US5606075AProcess for the synthesis of benzo[b]thiophenesLILLY CO ELI·Filed 1995·Granted Feb 25, 1997·5 cites·25 claims
- 1952US2018057484A1Processes and intermediates for the preparation of a pde10 inhibitorOMEROS CORP·Filed 2017·Application pending·0 cites
- 2051US8859796B1Synthetic and purification methods for phosphaplatin compounds and uses thereofPHOSPLATIN THERAPEUTICS LLC·Filed 2014·Granted Oct 14, 2014·0 cites·31 claims
- 2151US4303591ARemoval of stannic chlorideLILLY CO ELI·Filed 1980·Granted Dec 1, 1981·3 cites·6 claims
- 2251US2022267323A1Synthesis of bicyclic inhibitors of histone deacetylaseALKERMES INC·Filed 2020·Application pending·0 cites
- 2351US2002173645A1Non-solvated crystalline 6-hydroxy-2- (4-hydroxyphenyl) -3- [4- (2-piperidinoethoxy) benzoyl] benzo [b] thiophene hydrochlorideFiled 2002·Application pending·0 cites
- 2450US8846964B2Synthetic method for phosphaplatin compoundsPHOSPLATIN THERAPEUTICS LLC·Filed 2013·Granted Sep 30, 2014·0 cites·21 claims
- 2545US9920045B2Solid state forms of a PDE10 inhibitorOMEROS CORP·Filed 2016·Granted Mar 20, 2018·0 cites·18 claims
- 2645US7012153B2Process for preparing benzoic acidsLILLY CO ELI·Filed 2003·Granted Mar 14, 2006·0 cites·9 claims
- 2745US5994547AProcess for preparing benzo[b]thiophenesLILLY CO ELI·Filed 1998·Granted Nov 30, 1999·6 cites·13 claims
- 2840US6921827B2Process for preparing 3-aryl-benzo{b} thiophenesLILLY CO ELI·Filed 2001·Granted Jul 26, 2005·0 cites·8 claims
- 2940US2004014672A1Novel crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochlorideFiled 2001·Application pending·0 cites
- 3039US11154529B2Phosphaplatin liquid formulationsPHOSPLATIN THERAPEUTICS INC·Filed 2017·Granted Oct 26, 2021·0 cites·20 claims
- 3136US5142038AProcess of enantiomeric separation of carbacephem intermediatesLILLY CO ELI·Filed 1991·Granted Aug 25, 1992·1 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Wayne Douglas Luke files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →